They have 25 projects, so they may not offer much information about SHP-622. I can see them providing info on their phase 3 projects listed in the slideshow, esp the resubmission of OPUS-3 to FDA.
If we don't hear anything by early Feb, then the Q&A section of the financials conference call in mid-Feb may be the best way to find out when we may hear about SHP-622.